Javier Cortes Selected Research

Javier Cortes Research Topics

Disease

106	Breast Neoplasms (Breast Cancer) 05/2024 - 03/2007
55	Neoplasms (Cancer) 12/2024 - 04/2007
25	Triple Negative Breast Neoplasms 05/2024 - 10/2014
10	Disease Progression 06/2023 - 03/2010
9	Pathologic Complete Response 08/2023 - 02/2015
9	Diarrhea 06/2023 - 12/2015
8	Neoplasm Metastasis (Metastasis) 10/2022 - 10/2014
7	Fatigue 12/2023 - 03/2011
7	Neutropenia 10/2022 - 03/2011
5	Nausea 12/2023 - 04/2012
4	Vomiting 12/2023 - 12/2015
3	Alopecia (Baldness) 12/2023 - 04/2012
3	Exanthema (Rash) 06/2023 - 10/2020
3	Brain Neoplasms (Brain Tumor) 01/2023 - 01/2003
3	Cardiotoxicity 09/2021 - 01/2009
3	Hypoxia (Hypoxemia) 06/2021 - 03/2017
3	Peripheral Nervous System Diseases (PNS Diseases) 03/2017 - 03/2011
2	Pneumonia (Pneumonitis) 07/2022 - 11/2015
2	Leukopenia 07/2022 - 05/2021
2	Sepsis (Septicemia) 01/2021 - 11/2015
2	Hypertension (High Blood Pressure) 01/2020 - 10/2014
2	Melanoma (Melanoma, Malignant) 01/2018 - 12/2015
2	Circulating Neoplastic Cells 01/2018 - 12/2015
2	Headache (Headaches) 10/2017 - 12/2015
2	Asthenia 10/2017 - 03/2011
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2004 - 01/2003
1	Glioblastoma (Glioblastoma Multiforme) 01/2023

Drug/Important Bio-Agent (IBA)

26	Hormones (Hormone)IBA 05/2024 - 11/2009
22	ErbB Receptors (EGF Receptor)IBA 01/2024 - 11/2009
20	Biomarkers (Surrogate Marker)IBA 05/2024 - 07/2013
20	eribulin FDA Link 10/2022 - 04/2010
16	Trastuzumab (Herceptin)FDA Link 10/2023 - 04/2007
14	pembrolizumabIBA 05/2024 - 01/2020
12	Paclitaxel (Taxol)FDA LinkGeneric 08/2023 - 01/2003
12	AnthracyclinesIBA 11/2021 - 09/2010
11	human ERBB2 proteinIBA 01/2023 - 03/2010
10	taxaneIBA 01/2021 - 09/2010
9	Capecitabine (Xeloda)FDA Link 10/2022 - 09/2010
7	Cyclin-Dependent Kinase 4IBA 05/2024 - 09/2020
7	pertuzumabIBA 10/2022 - 03/2010
7	Gemcitabine FDA Link 10/2022 - 01/2003
7	Carboplatin (JM8)FDA LinkGeneric 10/2022 - 12/2015
6	abemaciclibIBA 01/2024 - 11/2020
6	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2022 - 06/2007
5	sacituzumab govitecanIBA 05/2024 - 04/2020
5	Aromatase InhibitorsIBA 06/2023 - 01/2017
5	Monoclonal AntibodiesIBA 01/2023 - 04/2007
5	Estrogen ReceptorsIBA 01/2022 - 04/2015
5	Proteins (Proteins, Gene)FDA Link 10/2021 - 08/2012
5	Bevacizumab (Avastin)FDA Link 11/2020 - 04/2009
4	exemestane (Aromasin)FDA Link 12/2023 - 01/2017
4	Tamoxifen FDA LinkGeneric 10/2023 - 01/2021
4	Ado-Trastuzumab EmtansineIBA 01/2023 - 09/2012
4	Immunoconjugates (Immunoconjugate)IBA 01/2023 - 05/2021
4	Vinorelbine (Navelbine)FDA LinkGeneric 10/2022 - 01/2003
4	130-nm albumin-bound paclitaxelIBA 12/2020 - 12/2015
4	Phosphotransferases (Kinase)IBA 01/2018 - 04/2007
3	Everolimus FDA Link 12/2023 - 10/2017
3	Fulvestrant (Faslodex)FDA Link 06/2023 - 04/2015
3	trastuzumab deruxtecanIBA 01/2023 - 01/2020
3	Antineoplastic Agents (Antineoplastics)IBA 01/2023 - 03/2011
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2022 - 12/2019
3	Lapatinib (GW572016)FDA Link 07/2022 - 04/2007
3	Taxoids (Taxanes)IBA 09/2021 - 03/2007
3	Phenobarbital (Luminal)FDA Link 11/2018 - 01/2018
3	Cell-Free Nucleic AcidsIBA 01/2018 - 07/2013
3	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 02/2014
3	Docetaxel (Taxotere)FDA Link 02/2017 - 03/2012
2	Epidermal Growth Factor (EGF)IBA 05/2024 - 12/2023
2	LigandsIBA 05/2024 - 01/2023
2	B7-H1 AntigenIBA 05/2024 - 01/2022
2	Immune Checkpoint InhibitorsIBA 01/2024 - 11/2020
2	ribociclibIBA 09/2023 - 12/2020
2	capivasertibIBA 06/2023 - 10/2020
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2022 - 01/2019
2	AntigensIBA 10/2022 - 01/2019
2	Epirubicin (Ellence)FDA LinkGeneric 10/2022 - 01/2020
2	durvalumabIBA 12/2021 - 11/2020
2	liposomal doxorubicin (Doxil)FDA Link 09/2021 - 01/2009
2	enzalutamideIBA 05/2021 - 01/2018
2	Androgen Receptors (Androgen Receptor)IBA 05/2021 - 01/2018
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 10/2020 - 04/2015
2	neratinibIBA 01/2020 - 12/2019
2	etirinotecan pegolIBA 01/2018 - 11/2015
2	ridaforolimusIBA 10/2017 - 01/2017
2	dalotuzumabIBA 10/2017 - 01/2017
2	nintedanibIBA 03/2017 - 03/2017
2	Analgesics (Analgesic Drugs)IBA 10/2014 - 04/2010
2	Cisplatin (Platino)FDA LinkGeneric 06/2004 - 01/2003
1	xentuzumabIBA 12/2023
1	Circulating Tumor DNAIBA 10/2023
1	margetuximabIBA 10/2023
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2023

Therapy/Procedure

55	Therapeutics 12/2024 - 01/2003
46	Drug Therapy (Chemotherapy) 05/2024 - 01/2003
9	Neoadjuvant Therapy 01/2023 - 11/2016
5	Radiotherapy 02/2024 - 01/2019
5	Immunotherapy 08/2023 - 01/2018
3	Aftercare (After-Treatment) 06/2023 - 10/2014
2	TP protocol 06/2004 - 01/2003